Six takeaways from the CMS administrator’s appearance at a D.C. think tank Monday — including who’s set to be the next ...

The sale will leave Owens & Minor focused on a smaller but potentially faster-growing and higher-margin business that ...

Executives from Stryker and Johnson & Johnson are on the hunt for deals, despite a turbulent environment, they said at ...

At AdvaMed’s annual conference, CEO Scott Whitaker addressed policy issues around tariffs, FDA staff cuts and the ongoing ...

Capacity at an R&D site in Boston will increase by 50% as part of a $600 million, 10-year commitment to the U.S.

MedSec CEO Michelle Jump spoke with MedTech Dive at AdvaMed’s annual meeting about the FDA’s shift from a “carrot” to a ...

At AdvaMed’s The MedTech Conference, executives said they’re incorporating AI in more devices, but figuring out how to use ...

The Sanofi partnership will support clinical validation and regulatory submissions for Revvity’s new assay. Elsewhere, ...

The medical device industry has a jam-packed year of events for professionals to attend, including the J.P. Morgan Healthcare ...

The device, called Biolinq Shine, is indicated for people with Type 2 diabetes who don’t depend on insulin.

The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.

Medical device supply chains face unique pressures. Regulatory bodies like the FDA demand rigorous traceability and ...